{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:06:23Z","timestamp":1781715983133,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00277-023-05320-4","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T07:03:03Z","timestamp":1687244583000},"page":"2507-2516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6097-5633","authenticated-orcid":false,"given":"Masuho","family":"Saburi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumi","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniko","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Ikegame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiyasu","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Ara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Transplant Complications Working Group of the Japanese Society for Transplantation and Cellular Therapy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"5320_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","volume":"9","author":"WJ Looney","year":"2009","unstructured":"Looney WJ, Narita M, M\u00fchlemann K (2009) Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9:312\u2013323","journal-title":"Lancet Infect Dis"},{"key":"5320_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1128\/CMR.11.1.57","volume":"11","author":"M Denton","year":"1998","unstructured":"Denton M, Kerr KG (1998) Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11:57\u201380","journal-title":"Clin Microbiol Rev"},{"key":"5320_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/CMR.00019-11","volume":"25","author":"JS Brooke","year":"2012","unstructured":"Brooke JS (2012) Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 25:2\u201341","journal-title":"Clin Microbiol Rev"},{"key":"5320_CR4","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1086\/522998","volume":"45","author":"A Safdar","year":"2007","unstructured":"Safdar A, Rolston KV (2007) Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45:1602\u20131609","journal-title":"Clin Infect Dis"},{"key":"5320_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10096-008-0518-2","volume":"27","author":"JI Paez","year":"2008","unstructured":"Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF (2008) Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis 27:901\u2013906","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5320_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/23744235.2018.1531145","volume":"51","author":"A Trifonova","year":"2019","unstructured":"Trifonova A, Strateva T (2019) Stenotrophomonas maltophilia - a low-grade pathogen with numerous virulence factors. Infect Dis (Lond) 51:168\u2013178","journal-title":"Infect Dis (Lond)"},{"key":"5320_CR7","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/cncr.21846","volume":"106","author":"M Boktour","year":"2006","unstructured":"Boktour M, Hanna H, Ansari S, Bahna B, Hachem R, Tarrand J et al (2006) Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer 106:1967\u20131973","journal-title":"Cancer"},{"key":"5320_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/BF01709374","volume":"15","author":"R Martino","year":"1996","unstructured":"Martino R, Mart\u00ednez C, Pericas R, Salazar R, Sol\u00e1 C, Brunet S et al (1996) Bacteremia due to glucose non-fermenting Gram-negative bacilli in patients with hematological neoplasias and solid tumors. Eur J Clin Microbiol Infect Dis 15:610\u2013615","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5320_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1086\/314043","volume":"31","author":"A Micozzi","year":"2000","unstructured":"Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S et al (2000) Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 31:705\u2013711","journal-title":"Clin Infect Dis"},{"key":"5320_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1086\/502197","volume":"24","author":"A Apisarnthanarak","year":"2003","unstructured":"Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ et al (2003) Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol 24:269\u2013274","journal-title":"Infect Control Hosp Epidemiol"},{"key":"5320_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10096-010-0882-6","volume":"29","author":"H Araoka","year":"2010","unstructured":"Araoka H, Baba M, Yoneyama A (2010) Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996\u20132009. Eur J Clin Microbiol Infect Dis 29:605\u2013608","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5320_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1399-3062.2011.00710.x","volume":"14","author":"H Araoka","year":"2012","unstructured":"Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K et al (2012) Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy. Transpl Infect Dis 14:355\u2013363","journal-title":"Transpl Infect Dis"},{"key":"5320_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/bmt.2012.87","volume":"48","author":"K Tada","year":"2013","unstructured":"Tada K, Kurosawa S, Hiramoto N, Okinaka K, Ueno N, Asakura Y et al (2013) Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage. Bone Marrow Transplant 48:74\u201379","journal-title":"Bone Marrow Transplant"},{"key":"5320_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00277-014-2028-x","volume":"93","author":"M Mori","year":"2014","unstructured":"Mori M, Tsunemine H, Imada K, Ito K, Kodaka T, Takahashi T (2014) Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases. Ann Hematol 93:901\u2013911","journal-title":"Ann Hematol"},{"key":"5320_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1186\/s12879-017-2745-6","volume":"17","author":"K Harada","year":"2017","unstructured":"Harada K, Sekiya N, Konishi T, Nagata A, Yamada Y, Takezaki T et al (2017) Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation. BMC Infect Dis 17:638","journal-title":"BMC Infect Dis"},{"key":"5320_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/ctr.12356","volume":"28","author":"S Shiratori","year":"2014","unstructured":"Shiratori S, Wakasa K, Okada K, Sugita J, Akizawa K, Shigematsu A et al (2014) Stenotrophomonas maltophilia infection during allogeneic hematopoietic stem cell transplantation: a single-center experience. Clin Transplant 28:656\u2013661","journal-title":"Clin Transplant"},{"key":"5320_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s15010-010-0023-2","volume":"38","author":"M Yeshurun","year":"2010","unstructured":"Yeshurun M, Gafter-Gvili A, Thaler M, Keller N, Nagler A, Shimoni A (2010) Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience. Infection 38:211\u2013215","journal-title":"Infection"},{"key":"5320_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1086\/313591","volume":"30","author":"JA Labarca","year":"2000","unstructured":"Labarca JA, Leber AL, Kern VL, Territo MC, Brankovic LE, Bruckner DA et al (2000) Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin Infect Dis 30:195\u2013197","journal-title":"Clin Infect Dis"},{"key":"5320_CR19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/bmt.2009.274","volume":"45","author":"R Chaplow","year":"2010","unstructured":"Chaplow R, Palmer B, Heyderman R, Moppett J, Marks DI (2010) Stenotrophomonas maltophilia bacteraemia in 40 haematology patients: risk factors, therapy and outcome. Bone Marrow Transplant 45:1109\u20131110","journal-title":"Bone Marrow Transplant"},{"key":"5320_CR20","first-page":"232","volume":"4","author":"KA Al-Anazi","year":"2014","unstructured":"Al-Anazi KA, Al-Jasser AM (2014) Infections Caused by Stenotrophomonas maltophilia in recipients of hematopoietic stem cell transplantation. Front Oncol 4:232","journal-title":"Front Oncol"},{"key":"5320_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s12185-013-1296-x","volume":"97","author":"H Demiraslan","year":"2013","unstructured":"Demiraslan H, Sevim M, Pala \u00c7, Durmaz S, Berk V, Kaynar L, Metan G (2013) Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients. Int J Hematol 97:414\u2013420","journal-title":"Int J Hematol"},{"key":"5320_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12879-015-0801-7","volume":"15","author":"SY Cho","year":"2015","unstructured":"Cho SY, Lee DG, Choi SM, Park C, Chun HS, Park YJ et al (2015) Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations. BMC Infect Dis 15:69","journal-title":"BMC Infect Dis"},{"key":"5320_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","volume":"103","author":"Y Atsuta","year":"2016","unstructured":"Atsuta Y (2016) Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol 103:3\u201310","journal-title":"Int J Hematol"},{"key":"5320_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","volume":"103","author":"J Kanda","year":"2016","unstructured":"Kanda J (2016) Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation. Int J Hematol 103:11\u201319","journal-title":"Int J Hematol"},{"key":"5320_CR25","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1038\/s41409-021-01291-0","volume":"56","author":"Y Inoue","year":"2021","unstructured":"Inoue Y, Okinaka K, Fuji S, Inamoto Y, Uchida N, Toya T et al (2021) Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study. Bone Marrow Transplant 56:2125\u20132136","journal-title":"Bone Marrow Transplant"},{"key":"5320_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1128\/AAC.01324-13","volume":"58","author":"YL Wang","year":"2014","unstructured":"Wang YL, Scipione MR, Dubrovskaya Y, Papadopoulos J (2014) Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. Antimicrob Agents Chemother 58:176\u2013182","journal-title":"Antimicrob Agents Chemother"},{"key":"5320_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1586\/eri.11.24","volume":"9","author":"IJ Abbott","year":"2011","unstructured":"Abbott IJ, Slavin MA, Turnidge JD, Thursky KA, Worth LJ (2011) Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Rev Anti Infect Ther 9:471\u2013488","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5320_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10096-007-0279-3","volume":"26","author":"AC Nicodemo","year":"2007","unstructured":"Nicodemo AC, Paez JI (2007) Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 26:229\u2013237","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5320_CR29","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1128\/AAC.38.3.624","volume":"38","author":"S Vartivarian","year":"1994","unstructured":"Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K (1994) A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother 38:624\u2013627","journal-title":"Antimicrob Agents Chemother"},{"key":"5320_CR30","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.cmi.2018.11.008","volume":"25","author":"JH Ko","year":"2019","unstructured":"Ko JH, Kang CI, Cornejo-Ju\u00e1rez P, Yeh KM, Wang CH, Cho SY et al (2019) Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. Clin Microbiol Infect 25:546\u2013554","journal-title":"Clin Microbiol Infect"},{"key":"5320_CR31","doi-asserted-by":"publisher","first-page":"269.e1","DOI":"10.1016\/j.jtct.2020.11.020","volume":"27","author":"M Kimura","year":"2021","unstructured":"Kimura M, Yamamoto H, Uchida N, Ogura S, Yamamuro R, Mitsuki T et al (2021) Stenotrophomonas maltophilia bloodstream infections in adult recipients of umbilical cord blood transplantation. Transplant Cell Ther 27:269.e1-269.e7","journal-title":"Transplant Cell Ther"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05320-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05320-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05320-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T12:09:31Z","timestamp":1692706171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05320-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5320"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05320-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"28 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HN reports Grants or contracts from Novartis, Astellas, Otsuka, Alexion, PPD-SNBL, Cmic, Meiji Seika, and Bristol-Myers Squibb; Consulting fees from Ono, Simon-Kucher & Partners, Daiichi Sankyo, and Novartis; Payment or honoraria (e.g., lecture fees) from Astellas, Otsuka, Sumitomo Dainippon, Takeda, Novartis, Bristol-Myers Squibb, Nippon Shinyaku, Astellas-Amgen, Shire, Celgene, Daiichi Sankyo, and Pfizer. ND reports Payment from Novartis Pharma and Janssen Pharma. The other authors declare no competing interests associated with this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}